Fresh guidelines and a reshaped regulatory framework pave the way for smoother clinical research, even as COVID-19 maintains …
Fresh guidelines and a reshaped regulatory framework pave the way for smoother clinical research, even as COVID-19 maintains …
An investigational RNA-based therapy shows significant reduction in disease-causing protein levels—potentially a meaningful step forward in treating Huntington’s …
Topical laquinimod reaches posterior eye tissues with dose-related distribution and good tolerability in patients preparing for vitrectomy
Early-stage data reveal tumour targeting and tolerability with radiolabelled GRPR antagonist therapy in metastatic prostate cancer
Vera Therapeutics completed full enrolment in its pivotal trial of atacicept in IgA nephropathy and Minovia Therapeutics received …
In a shareholder letter released on 1 April 2025, MAIA Biotechnology revealed plans to advance telomere‐targeted therapies in …
Novartis receives a landmark approval for iptacopan (Fabhalta®), offering new hope for patients with a rare kidney disorder.
Precision BioSciences receives IND clearance to launch US-based trial of PBGENE-HBV, a meganuclease gene-editing candidate for a functional …
Long-term clinical data from Roche strengthen the case for disease-modifying therapies in spinal muscular atrophy and Duchenne muscular …
March 2025 is marked by significant deal-making, promising clinical trial results, and innovations across small molecules, biologics, and …
Already a subscriber? Log in